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Late In-the-Bag Intraocular Lens Dislocation
A Randomized Clinical Trial Comparing Lens Repositioning
and Lens Exchange
Olav Kristianslund, MD,1,2 Marianne Råen, MPhil,1 Atle E. Østern, MD, PhD,1 Liv Drolsum, MD, PhD1,2
Purpose: To compare the efﬁcacy and safety of 2 operation methods for late in-the-bag intraocular lens (IOL)
dislocation.
Design: Prospective, randomized, parallel-group surgical trial.
Participants: Patients referred to Oslo University Hospital (tertiary referral center).
Methods: We randomly assigned 104 patients (104 eyes) either to IOL repositioning by scleral suturing
(n ¼ 54) or to IOL exchange with retropupillary ﬁxation of an iris-claw IOL (n ¼ 50). One surgeon performed all
operations. Patients were evaluated comprehensively before surgery, and most patients (82%) attended an
examination 6 months after surgery.
Main Outcome Measures: Best-corrected visual acuity (BCVA) 6 months after surgery.
Results: The mean postoperative BCVA was 0.240.29 logarithm of the minimum angle of resolution (log-
MAR) units (range, 0.18 to 1.16 logMAR) in the repositioning group and 0.350.54 logMAR (range, 0.20 to 3.0
logMAR) in the exchange group (P ¼ 0.23). A BCVA of 20/40 or better (Snellen) was reached by 61% and 62% of
the patients, respectively (P ¼ 0.99). The mean postoperative corneal cylinder was 1.21.0 and 1.20.8 diopters,
respectively (P ¼ 0.84), and the postoperative endothelial cell density changes were 310% (P ¼ 0.07)
and 1014% (P ¼ 0.001), respectively (group difference, P ¼ 0.04). Repositioning had a longer mean surgical
time than exchange (P < 0.001). There were 2 (4%) and 0 cases of perioperative ﬂuid misdirection syndrome,
respectively. Postoperative complications were intraocular pressure (IOP) increase (n ¼ 12), cystoid macular
edema (CME; n ¼ 3), and nonarteritic anterior ischemic optic neuropathy (n ¼ 1) in the repositioning group, and
IOP increase (n ¼ 9), pupillary block (n ¼ 1), choroidal effusion (n ¼ 2), CME (n ¼ 4), and redislocation (n ¼ 1) in the
exchange group.
Conclusions: We found satisfactory and not signiﬁcantly different outcomes for BCVA 6 months after sur-
gery in the 2 groups. Both operation methods seemed safe, with low frequencies of serious perioperative and
postoperative complications. However, some of the observed differences in complications should be taken into
consideration when selecting the most suitable method in clinical practice. Ophthalmology 2016;-:1e9 ª 2016by
the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).In-the-bag intraocular lens (IOL) dislocation is considered a
late complication of cataract surgery and is diagnosed an
average of 6 to 9 years after in most cases uneventful sur-
gery.1e7 Dislocation of the IOLecapsule complex was
almost nonexistent and not recognized until the advent of
continuous curvilinear capsulorrhexis and was ﬁrst
described in 1993.8 Several studies have reported an
increasing trend in recent years.1,7,9e11
Pseudoexfoliation syndrome (PEX) has been established
as an important risk factor for late in-the-bag IOL dis-
location.1,3e7,11e14 Pseudoexfoliation syndrome is associ-
ated with weak zonulae and contraction of the anterior
capsule, which gradually may result in loosening of the
IOLecapsule complex and eventually dislocation.1,5,8,15
Pseudoexfoliation syndrome has a high prevalence in
Scandinavian countries, and previous studies have detected
pseudoexfoliative material in 11% to 17% of the patientsª 2016 by the American Academy of Ophthalmology
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/). Published by Elsevier Inc.referred to our department for cataract surgery.16e18 Other
conditions shown to predispose patients to late in-the-bag
IOL dislocation, presumably through loosening of the zon-
ulae, are previous vitreoretinal surgery,1,2,19 myopia/
increased axial length,2,10,12 uveitis,1,3 retinitis pigmen-
tosa,2,12 trauma,1e3 and certain connective tissue
disorders.20
The optimal management for late in-the-bag IOL dislo-
cation is still being questioned. In principle, there are 2
different surgical approaches: repositioning of the existing
IOL by ﬁxating it either to the scleral wall or to the iris, or
exchanging the IOLecapsule complex with a new IOL.
Although different operating techniques have been
compared previously, these studies have applied mainly a
retrospective research design and most have included few
patients.2e4,6,7,11,12,14,21e23 To the best of our knowledge,
no other randomized clinical trial comparing surgical1http://dx.doi.org/10.1016/j.ophtha.2016.10.024
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been conducted previously. In the present trial, we
compared, by randomization of study participants, IOL
repositioning by scleral suturing versus IOL exchange with
an iris-claw lens. The aim was to compare the efﬁcacy and
safety of these 2 principally different operation methods.
Methods
We performed a randomized clinical trial of patients referred to the
Department of Ophthalmology at Oslo University Hospital (tertiary
referral clinic) with late in-the-bag IOL dislocation between
January 2013 and December 2015. Referred patients were
considered consecutively for eligibility.
The inclusion criteria were as follows: IOL dislocation more
than 6 months after cataract surgery, IOL inside the capsule and
visible in the pupillary area in the supine position, eligibility for
both operation methods, ability to cooperate fairly well during the
examinations, and willingness to participate in the study. Reposi-
tioning surgery was considered unsuitable when a suture loop
around the haptic could not be made (such as plateehaptic IOLs
without holes in the peripheral part) or in patients requiring a
change in IOL refraction. Exchange with an iris-claw IOL was not
considered a proper technique in eyes with active uveitis; in the
presence of a pathologic iris, such as large defects, much atrophy,
or pronounced iridodonesis; or in eyes that previously had under-
gone Descemet’s stripping automated endothelial keratoplasty.
Totally dislocated IOLs into the posterior segment of the eye
requiring pars plana vitrectomy were not included. We also did not
include patients who before cataract extraction had a subluxated
lens in need of surgery with a Cionni capsular tension ring (e.g.,
Marfan syndrome patients with ectopia lentis), because resuturing
of the ring was considered the most appropriate operation method
in these cases. For patients with dislocated IOLs in both eyes
during the study period, only the ﬁrst operated eye was included.
As shown in Figure 1, a total of 175 patients (180 eyes) with
late in-the-bag IOL dislocation were referred in the speciﬁed
period. Of these, 104 patients (104 eyes) were enrolled. We used a
computer program for randomization that provided random
permuted blocks. An optometrist who did not take part in the
evaluation of eligibility or the surgery assigned patients to treat-
ment groups. Enrolled patients were randomized (1:1) either to IOL
repositioning with suturing of the haptics to the scleral wall (n ¼
54) or to removal of the IOLecapsule complex followed by
replacement with a retropupillary iris-claw IOL (n ¼ 50). Reasons
for exclusion are presented brieﬂy in Figure 1.
Preoperative Examination
Time since cataract surgery and predisposing conditions were
registered before surgery. Pseudoexfoliation syndrome status was
determined based on the presence of dandruff-like material on the
pupillary edge or if PEX was noted in the patient medical records
before cataract surgery. Refraction and measurement of the best-
corrected visual acuity (BCVA) were performed applying the
Early Treatment Diabetic Retinopathy Study visual acuity chart
with standardized lighting conditions in the room. In cases of
substantially dislocated IOLs, a correction for aphakia was per-
formed during visual acuity measurement. Best-corrected visual
acuity values were converted to logarithm of the minimum angle of
resolution (logMAR) values for statistical analysis and are pre-
sented as logMAR values unless otherwise stated. Goldman
applanation tonometry was conducted before pupillary dilation.
The degree of IOL dislocation was evaluated with slit-lamp ex-
amination and photography of the anterior segment. We used the2following classiﬁcation: grade 1, small decentration with the optic of
the IOL still covering the visual axis, oftenwith pseudophakodonesis
and a gap between the pupillary edge and the IOL; grade 2, the
equator of the optic approximately in the visual axis; and grade 3, the
IOLmore decentered than grade 2, but at least 1 haptic still visible in
the pupillary area. There was uncertainty about the BCVA mea-
surement in several cases with dislocation grade 2 or 3 because of
visual interference from the IOL edge or the haptics or non-
transparent material in the superior part of the capsule.
Surgical Procedure
All operations were performed using retrobulbar anesthesia by the
same surgeon (L.D.), who has long experience with both surgical
procedures. The pupil was dilated with cyclopentolate 10 mg/ml
and phenylephrine 100 mg/ml twice 5 minutes apart, 30 to 60
minutes before surgery. The size of the pupil was measured with a
strabismus caliper at the start of surgery. A cohesive viscoelastic
(Healon GV OVD, Abbott Laboratories Inc., Abbott Park, IL) was
used and removed at the end of surgery. Thereafter, 1 mg cefur-
oxime was installed into the anterior chamber. If present, vitreous
strands were removed from the incision wound by a cellulose
sponge applied externally followed by gently cutting with scissors,
as well as internally sweeping possible incarcerated vitreous from
the wound (termed removal of vitreous strands from the incision).
In very old patients with liqueﬁed vitreous humor, this procedure
often was judged as sufﬁcient. Otherwise, anterior vitrectomy was
performed, if necessary, using the Stellaris Vision Enhancement
System phacoemulsiﬁcation machine (Bausch & Lomb, Rochester,
NY). We recorded the surgical time (from the ﬁrst incision to the
removal of the surgical drape at the end of the operation). The
clock was stopped if the surgeon had to wait for unpacking of
instruments that were not prepared on the instrument table. We also
registered whether a capsular tension ring was present, the type of
IOL, and any perioperative complications.
Suturing of the Haptics to the Scleral Wall (Repositio-
ning). Repositioning surgery was performed using the ab externo
suture loop closed-system ﬁxation technique, which has been used
by several other investigators and is illustrated and described in
detail by Chan et al.24 Iris hooks were used if the haptics could not
be identiﬁed. A scleral triangular ﬂap was made behind the limbus
corresponding to the superior haptic location, followed by a limbal
incision approximately 180 apart. A straight needle on a 10-
0 Prolene suture (Ethicon, Sommerville, NJ) was introduced
through the limbal incision. Thereafter, a bent 27-gauge cannula
was introduced under the scleral ﬂap, through the scleral wall,
beneath the middle part of the haptic, through the capsule, and into
the straight needle, followed by retraction of the needleecannula
complex from the scleral incision port. This procedure was
repeated with the cannula in front of the IOLecapsule complex,
making a loop around the haptic. Then the entire procedure was
repeated at the opposite site. For exactly 180 alignment of the 2
Prolene sutures, a Mendez degree gauge, which is a measuring
instrument with 10 increments, was used to mark the limbus to
avoid tilt and decentration of the IOL. For the same reason, the
sutures were adjusted before tightening the knots. In cases of 3
closed haptics, 3 loops were made. The sutures were placed 1 to 2
mm behind the limbus to ensure that the haptics within the capsular
bag were anchored away from the posterior iris to avoid friction.
Finally, the scleral ﬂaps were placed over the suture knots. The
conjunctiva was sutured with 10-0 nylon.
Replacing the Intraocular LenseCapsule Complex with a
Retropupillary Iris-Claw Intraocular Lens (Exchange). The
IOLecapsule complex was luxated into the anterior chamber using
cohesive viscoelastics and the viscoelastics cannula, followed by
explantation through a 5.5-mm scleral pocket arcuate incision at the
Figure 1. Study ﬂowchart showing 6 months of follow-up. yExclusions from speciﬁc analyses because of missing data are commented on elsewhere.
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peripheral corneal incision was made, ensuring that the incision did
not interfere with the ﬁltration site. In some cases, acetylcholine
(Miochol-E, Bausch & Lomb, Rochester, NY) was injected to
constrict the pupil before IOL implantation. A Verisyse aphakic iris-
claw IOL (VRSA54; Abbott Laboratories, Inc., Abbott Park, IL),
which is similar to the Artisan aphakic IOL (OphtecBV, Groningen,
TheNetherlands), was implanted with the concavity forward into the
anterior chamber, and then enclavated nasally and temporally behind
the iris by a thin spatula through a stab incision in the temporal
position. No iridectomy was performed. The scleral pocket incision
was closed with a single 10-0 nylon cross-suture. All patients
received acetazolamide 500 mg (tablet) on the day of surgery and
topical treatment with a mixture of corticosteroid and chloram-
phenicol 5 times daily for 1 week, followed by 3 times daily for 2
weeks.
Postoperative Examination
Six months after surgery, a thorough examination was conducted
by the same ophthalmologist and optometrist as before surgery,
and the same parameters were measured. In addition, we registered
any postoperative complications. An IOP increase was deﬁned as a
postoperative rise in IOP demanding a sustained treatment change
in the postoperative period.
The corneal cylinder and axis were evaluated before surgery
and after surgery by Scheimpﬂug topography (Pentacam HR;
Oculus Optikgeräte GmbH, Wetzlar, Germany), measuring the
keratometry readings in diopters and the axis in degrees. Corneal
topography was not measured in 13 patients before surgery nor in 6
patients after surgery because of technical difﬁculties.We evaluated the macular region by optical coherence tomog-
raphy (OCT; Nidek RS 3000; Nidek Co., Ltd., Aichi, Japan) before
surgery, unless there was too much visual disturbance, and after
surgery and assessed whether cystoid macular edema (CME) was
present 6 months after surgery. In addition, we measured the
central macular thickness, in this study deﬁned as the central area
of the Early Treatment Diabetic Retinopathy Study macular
thickness map presented by the OCT software (Navis-EX, version
1.4.2.1 Nidek Co., Ltd., Aichi, Japan), which included the retinal
pigment epithelium. In a few cases, this was not possible because
of lack of cooperation by the patient or unclear photographs. A
postoperative OCT examination with images clear enough for
evaluation of both CME and central macular thickness was per-
formed on 35 patients in the repositioning group and 37 patients in
the exchange group. All patients attending the postoperative ex-
amination underwent a clinical evaluation of the macular region,
which included an assessment of the possible presence of CME.
Eleven patients (20%) in the repositioning group and 8 patients
(16%) in the exchange group were lost to follow-up; 18 had serious
illness and 1 died. We managed to collect some postoperative infor-
mation from our clinic or from private ophthalmologists about all
except 4 of these patients. From the available information, it seems that
their IOLs were well positioned, and no cases of reoperations, retinal
detachment, endophthalmitis, or vitreous hemorrhage were reported.
Endothelial Cell Density Measurements
The central endothelial cell density (ECD) was measured before
and after surgery with a noncontact confocal microscope
(ConfoScan 4; Nidek Technologies Srl, Padova, Italy). We applied
the embedded analysis program and measured both in automatic3
Ophthalmology Volume -, Number -, Month 2016mode and in semimanual mode. Each patient’s clearest image
before surgery and 6 months after surgery was chosen for analysis.
A rectangular frame (predeﬁned by the software) with an area of
0.0935 mm2 was placed preferably in the center of the image and
secondarily at another location where the image was clearer. Three
automatic countings were performed with small variations in the
localization of the frame, and the one with the median value was
chosen and denoted the automatic ECD. At the exact same local-
ization and within the same frame, a semimanual ECD count was
performed by manually marking all whole cells, as well as cells
intersecting the superior and left frame edge, followed by a
calculation of the ECD by the embedded software. The automatic
analysis seemed to overestimate the ECD value, especially at lower
ECDs. We therefore chose to use the semimanual values only.
Technical failure, challenges in patient cooperation, and images
that were not clear enough for analysis resulted in a lack of ECD
measures for 23 patients before surgery and 17 patients after sur-
gery. We analyzed the ECD change only for patients with satis-
factory recordings both before surgery and after surgery
(repositioning group, n ¼ 32; exchange group, n ¼ 29).
Statistical Methods and Ethics
For the sample size calculationwe chose visual function (logMAR) 6
months after surgery as the efﬁcacy variable. Because a limited
number of patients are referred with late in-the-bag IOL dislocation,
we realized that we could not design a study able to detect minor
between-group differences. As a compromise, we accepted a
between-group difference of 0.15 logMAR as clinically relevant.
Furthermore, with an expected standard deviation of 0.2, an intended
test power of 80%, and a 5% signiﬁcance level, 28 eyes in each group
were required. We expected some loss to follow-up because of the
advanced patient age, and therefore decided to enroll at least 50 eyes
in each operation group. This was considered advantageous to retain
the test power even beyond 6 months of follow-up.
For comparison between the 2 groups, we used chi-
square tests and 2-sample t tests. For comparison of data
within each group before and after surgery, we used a
paired-samples t test. Continuous data were assessed for
normality to clarify t test suitability. We conducted 2-sided
signiﬁcance testing and applied a signiﬁcance level of 5%.
Statistical analysis was performed with the SPSS software
version 21.0 (IBM Corp., Armonk, NY), and for categorical
data, we applied the Exact calculation option provided by
the software. Results are presented as meanstandard
deviation (range, minimumemaximum) or number
(percentage), unless otherwise stated. In the group com-
parison of BCVA and ECD, the 95% conﬁdence interval of
the mean difference between the groups also is presented.
Research approval was obtained from the Regional Committees
for Medical and Health Research Ethics, and the study has been
registered at ClinicalTrials.gov (identiﬁer, NCT01784926). The
research adhered to the Declaration of Helsinki, and written
informed consent was obtained from all study participants. Patients
were provided thorough information about the surgery and possible
complications, and thus were not masked to which treatment they
received. For obvious reasons, the surgeon and the clinical
examiner at the postoperative visit could not be masked. The
examiner was masked to the group afﬁliation during the ECD and
OCT analyses.Results
Of the 180 eyes (175 referred patients) assessed for eligibility, 116
eyes (64%) had signs of PEX. Other encountered predisposing4conditions were myopia (15%), previous vitreoretinal surgery
(14%), trauma (8%), chronic uveitis (7%), and retinitis pigmentosa
(0.5%). Fifteen eyes (8%) had no known predisposing condition,
whereas some had more than 1 condition. Mean time since cataract
surgery for referred patients was 10.34.7 years.
Baseline characteristics and preoperative study parameters
for the enrolled patients are presented in Table 1. Age, gender,
time since cataract surgery, and predisposing conditions were
almost equal between the 2 groups. Preoperative BCVA was
better in the repositioning group. However, mainly eyes with
dislocation grade 3 and substantially compromised BCVA
were distributed unequally, as can be seen from Table 1.
Surgery. Operation parameters are shown in Table 2. The
group comparison revealed that IOL repositioning had a longer
surgical time (P < 0.001) and a tendency for more intraocular
hemorrhage (P ¼ 0.12), whereas IOL exchange required more
anterior vitrectomies (P < 0.001) or removal of vitreous strands
from the incision (P ¼ 0.004), and such patients experienced
more iris injuries (P ¼ 0.001). All 4 cases of intraocular
hemorrhage occurred in the repositioning group, 3 resulting from
the scleral incision and 1 resulting from iris manipulation
(3 regressed spontaneously in a short time), whereas all 9 cases
of iris injury occurred in the exchange group (7 were only minor
iris sphincter ruptures). Two patients experienced ﬂuid
misdirection syndrome at the end of IOL repositioning surgery.
One was easily resolved, whereas the other had a complicated
postoperative course. Table 2 provides some more details
regarding perioperative complications.
Main Outcome Measure. As shown in Table 3, the mean
BCVA 6 months after surgery was 0.240.29 logMAR
(range, 0.18 to 1.16 logMAR) in the repositioning group and
0.350.54 logMAR (range, 0.20 to 3.0 logMAR) in the
exchange group. The difference between the 2 groups was not
statistically signiﬁcant (95% conﬁdence interval, 0.29 to 0.08;
P ¼ 0.23). Both groups had a signiﬁcant improvement in BCVA
(P ¼ 0.008 and P ¼ 0.04, respectively), with no signiﬁcant
group difference (P ¼ 0.37). The mean postoperative BCVA for
all patients (n ¼ 85) was 0.290.43 logMAR (range, 0.20 to
3.0 logMAR).
Other Postoperative Outcomes. Corneal astigmatism, post-
operative complications, and central macular thickness are pre-
sented along with some comments in Table 3. Compared with the
preoperative value, 9 patients (21%) in the repositioning group and
11 patients (26%) in the exchange group experienced a worsening
of BCVA after surgery. All these patients, along with presumed
reasons for worsening BCVA, are listed in Table 4.
Endothelial cell density (semimanual counting) changed
by 310% in the repositioning group and 1014% in the
exchange group after surgery. This change was statistically sig-
niﬁcant only in the exchange group (repositioning, P ¼ 0.07; ex-
change, P ¼ 0.001). The difference in ECD loss between the 2
groups was statistically signiﬁcant (95% conﬁdence
interval, 0.5% to 10.9% loss; P ¼ 0.04).Discussion
In this study, 104 patients with late in-the-bag IOL dislo-
cation were assigned randomly either to repositioning of the
IOLecapsule complex by scleral suturing or to IOL ex-
change with a retropupillary iris-claw IOL. With its ran-
domized research design this trial provides important new
knowledge about operation methods for IOL dislocation.
Both groups achieved satisfactory postoperative outcomes
Table 1. Late In-the-Bag Intraocular Lens Dislocation: Baseline Characteristics in the 2 Surgical Groups
Repositioning (n [ 54) Exchange (n [ 50)
Age (yrs) 81.19.4 (56e94) 82.36.2 (63e95)
Gender (male/female) 20 (37)/34 (63) 21 (42)/29 (58)
Time since cataract surgery (yrs) 10.64.3 (1e20) 10.04.3 (3e20)
Predisposing conditions*
PEX 42 (78) 44 (88)
Myopiay 10 (19) 7 (14)
Vitreoretinal surgery 5 (9) 8 (16)
Trauma 4 (7) 6 (12)
Chronic uveitis 3 (6) 1 (2)
Unknown 3 (6) 0 (0)
Glaucoma or recently identiﬁed high IOPz 31 (57) 31 (62)
Grade of IOL dislocation
1 (small) 22 (41) 14 (28)
2 (moderate) 16 (29.5) 11 (22)
3 (pronounced) 16 (29.5) 25 (50)
Preoperative measures
BCVA (logMAR)x 0.370.42 (0.2 to 2.5) 0.640.77 (0.08 to 3.0)
IOL dislocation grade 1 0.210.22 (0.2 to 0.66) 0.330.32 (0.02e1.02)
IOL dislocation grade 2 0.500.38 (0.06 to 1.60) 0.52 0.26 (0.12e0.92)
IOL dislocation grade 3 0.460.58 (0.06 to 2.5) 0.871.01 (0.08 to 3.0)
Corneal cylinder (diopters) 1.20.9 (0.0e3.4) (n ¼ 49) 1.10.6 (0.2e2.5) (n ¼ 42)
Flattest corneal axis (degrees) 99.858.1 (6e180) 10157.9 (2e180)
IOP (mmHg) 17.75.0 (7e31) 18.37.2 (8e36)
ECD (cells/mm2)x 1940418 (1091e2855) (n ¼ 44) 1718449 (770e2790) (n ¼ 37)
BCVA ¼ best-corrected visual acuity; ECD ¼ endothelial cell density; IOL ¼ intraocular lens; IOP ¼ intraocular pressure; logMAR ¼ logarithm of the
minimum angle of resolution; PEX ¼ pseudoexfoliation syndrome.
Data are mean  standard deviation (range) or no. (%). BCVA group comparison: independent samples t test, signiﬁcant group difference overall (P ¼
0.03), but not in subgroup analysis (P > 0.05 all 3 groups); nonparametric test (ManneWhitney U test), not signiﬁcant group difference overall (P ¼ 0.18)
or in subgroup analysis (P > 0.05 all 3 groups).
*Some patients had more than 1 predisposing condition.
yMyopia 4 diopters before cataract surgery.
zHigh preoperative IOP (22 mmHg) despite no prior diagnosis of glaucoma or ocular hypertension.
xStatistically signiﬁcant difference for group comparison: 0.05 < P > 0.01, t test.
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operative or postoperative complications.
An increase in the rate of in-the-bag IOL dislocations has
been reported in the past decade.1,7,10,21 However, a
consensus regarding the choice of operation methods is yet
to be reached. In cases where the IOLecapsule complex has
dislocated completely into the posterior pole, a pars plana
approach is required. Otherwise, the surgical access gener-
ally depends on the surgeon’s preferences. In several eye
clinics, vitreoretinal surgeons operate all the IOL disloca-
tions. In other clinics, such as in ours, cataract surgeons
traditionally manage these patients on the condition that the
IOLecapsule complex can be identiﬁed in the pupillary
area. Both with the anterior access and pars plana ap-
proaches, the IOL either can be repositioned or exchanged,
and different approaches for ﬁxation and positioning of the
IOL have been used.25
Using an anterior surgical approach and positioning of
the IOL behind the iris in all patients, we chose to compare 2
principally different operation methods. Both groups expe-
rienced a signiﬁcant improvement in visual acuity after
surgery, and more than 60% of the patients reached a BCVA
of 20/40 or better at the 6-month postoperative follow-up
visit. We found no signiﬁcant difference in the post-
operative BCVA between the 2 groups, which seems toimply that the operation methods had similar efﬁcacy in
terms of visual outcome. The proportions of the patients
with an improvement, deterioration, or no change in BCVA
were almost equal in the 2 operation groups, which further
supports our conclusion of similarity. This is also consistent
with ﬁndings from previous studies that compared IOL
repositioning with IOL exchange.6,7,23 However, these
studies had a retrospective, nonrandomized research design
and to some extent applied different surgical approaches and
positioning of the IOL.
The mean postoperative BCVA of 0.3 logMAR in our
study was similar to what we demonstrated previously in a
retrospective study7 and is more favorable than the mean
postoperative BCVA of 0.4 to 0.5 logMAR that most
other IOL dislocation surgery studies have
reported.2,4,6,11,14,23 As an exception, one recent study22
measured a mean of 0.2 logMAR in 1 of the operation
groups (scleral suturing). It should be mentioned,
however, that the distribution of predisposing conditions,
ocular comorbidity, and age may affect the comparability
between these studies. Increased induced surgical
astigmatism resulting from a large incision has been
emphasized as one of the disadvantages of IOL exchange
surgery.12,25 However, consistent with previous research,26
the scleral pocket arcuate incision used in our study5
Table 2. Comparison of Perioperative Parameters and Complica-
tions in the 2 Groups: Intraocular Lens Repositioning versus
Exchange
Repositioning
(n [ 54)
Exchange
(n [ 50)
P
Value
Surgical time (min) 23.65.6 (16.9e46.9) 14.13.2 (8.0e22.2) <0.001
Pupil size (mm) 5.81.1 (3.5e9.0) 6.01.2 (4.0e9.0) 0.38
IOL type
1-piece foldable 15 14 0.54
1-piece rigid 2 3
3-piece foldable 25 21
Plate design, no
haptics
2 0
Plate design, 3
haptics
1 3
Plate design, 4
haptics
3 7
Other 6 2
Capsular ring 5 (9) 5 (10) 0.99
Additional surgical
factors
Anterior
vitrectomy
0 (0) 20 (40) <0.001
Removal of
vitreous strands
from the
incision
4 (7) 15 (30) 0.004
Perioperative
complications
Intraocular
hemorrhage*
4 (7) 0 (0) 0.12
Iris injuryy 0 (0) 9 (18) 0.001
Other
complicationsz
2 (4) 0 (0) 0.50
IOL ¼ intraocular lens.
Data are mean  standard deviation (range), no., or no. (%).
*n ¼ 3 with complete regression and n ¼ 1 with almost complete regres-
sion within 6 months.
yn ¼ 7 with minor iris sphincter ruptures, n ¼ 1 with difﬁcult enclavation
resulting in several iris holes, and n ¼ 1 with frequent iris prolapse to the
incision resulting in a peripheral iridectomy being performed.
zPresumed ﬂuid misdirection syndrome, with intraocular pressure increase
and shallowing of the anterior chamber. One case was initially suspected to
be an expulsive hemorrhage, but this was not conﬁrmed by ultrasound, and
the eye underwent reoperation with a pars plana vitrectomy and iridec-
tomy. The other case was treated successfully during the operation with a
posterior capsule opening and iridectomy.
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difference compared with the repositioning group.
The 2 operation methods to be compared differed in
duration and perioperative complications. The mean surgical
time was longer for IOL repositioning than for IOL ex-
change. Furthermore, intraocular hemorrhage occurred only
during repositioning surgery, whereas iris injuries and the
need for anterior vitrectomies occurred only during ex-
change surgery. These differences were expected because
passing a needle through the vascularized sclera may lead to
hemorrhage, whereas removal of the entire IOLecapsule
complex increases the risk of iris injury, especially in eyes
with PEX and poorly dilated pupils. Furthermore, when the
IOLecapsule complex is manipulated into the anterior
chamber during exchange surgery, it is much more likely6that the anterior hyaloid membrane, with its closeness to the
posterior capsule, will break and cause vitreous prolapse,
compared with during repositioning surgery. This explains
the group difference in the requirement for anterior vitrec-
tomy. All except one of the intraocular hemorrhages cleared
spontaneously in a short time, and none of the iris injuries
were succeeded by postoperative difﬁculties. There were,
however, 2 cases of ﬂuid misdirection syndrome during
repositioning surgery, one of which resulted in a deterio-
rated visual acuity.
The 2 most frequently encountered postoperative com-
plications were IOP increase (25%)dwith 12 cases (28%)
in the repositioning group and 9 cases (21%) in the ex-
change groupdand CME (8%), with 3 cases (7%) and 4
cases (10%), respectively. In patients with glaucoma, high
preoperative IOP, or both, it can be difﬁcult to distinguish
whether the increase in IOP is primarily a postoperative
complication, or rather part of a glaucoma condition itself.
This aspect is discussed elsewhere (Kristianslund et al 2016,
unpublished data). In the exchange group, 1 patient expe-
rienced a pupillary block that was easily resolved by laser
iridotomy, and 2 patients experienced postoperative
choroidal effusion that resolved without surgery. No pa-
tients experienced these complications in the repositioning
group. The risk of choroidal effusion likely is related to the
large incision in IOL exchange compared with the more
closed system with scleral suturing. Surgeons should be
aware of this risk and thus strive to prevent persistent
hypotony during exchange surgery. Positioning of single-
piece foldable acrylic IOLs with thick haptics in the sul-
cus is not recommended because of an increased risk of iris
chaﬁng, uveitiseglaucomaehyphema syndrome, and sec-
ondary vitreous hemorrhage.27 In the present study, only
patients with dislocated IOLs positioned entirely in the
lens capsule were included; thus repositioning of single-
piece foldable acrylic IOLs was not contraindicated, and
complications directly related to these IOLs were not
observed.
Postoperative complication rates in our study were low
compared with those of previous studies, especially
regarding redislocations (n ¼ 1) and retinal detachment (n ¼
0). Various studies of in-the-bag IOL dislocation surgery
have reported postoperative CME in 2% to 12% of the pa-
tients,3,4,6,12,14 redislocations in 2% to 10% of the pa-
tients,3,4,6,11,12,14 and retinal detachment in 3% to 8% of the
patients.2e4,11,12An IOP increase is deﬁned unequally in
earlier studies, and hence reported proportions have varied
considerably.6,12,14 As noted previously, our perioperative
complication rates also were acceptable. Hence, both oper-
ation methods as performed in this study seem to be safe.
Nevertheless, we emphasize the importance of informing the
patients that this type of surgery is associated with a
considerably higher risk of complications than modern
cataract extraction and that postoperative visual outcome is
more uncertain.
Although a postoperative improvement in BCVA was
common (54%), approximately 23% of the patients in each
group experienced a deterioration of the BCVA. Of these,
9% in the repositioning group and 7% in the exchange
group were considered directly related to the dislocation
Table 3. Postoperative Outcomes 6 Months after Surgery: Intraocular Lens Repositioning versus Exchange
Repositioning (n [ 43)* Exchange (n [ 42)* P Valuey
BCVA
logMAR 0.240.29 (0.18 to 1.16) 0.350.54 (0.20 to 3.0) 0.23
20/40 (Snellen) 26 (61) 26 (62) 0.99
IOP (mmHg) 16.55.2 (9e34) 14.94.2 (8e29) 0.13
ECD (cells/mm2) 1858433 (887e2641) (n ¼ 37) 1514470 (545e2577) (n ¼ 33) 0.002
BCVA change (logMAR) 0.150.35 (P ¼ 0.008; n ¼ 43) 0.280.84 (P ¼ 0.04; n ¼ 42) 0.37
BCVA before vs. after surgery
Better 23 (54) 23 (55) 0.63
Equal (0.04 logMAR) 11 (26) 8 (19)
Worse 9 (21) 11 (26)
Corneal cylinder (diopters) 1.21.0 (0.1e5.7) (n ¼ 40) 1.20.8 (0.2e4.6) (n ¼ 39) 0.84
Flattest corneal axis (degrees) 90.651.8 (3e174) 82.548.3 (4e180) 0.48
ECD change (cells/mm2) 52157 (P ¼ 0.07; n ¼ 32) 163245 (P ¼ 0.001; n ¼ 29) 0.04
ECD change (% of preoperative value) 310% 1014% 0.04
CMT (mm) 29159 (215e489) (n ¼ 35) 30672 (170e555) (n ¼ 37) 0.30
CMT change (mm)z þ1036 (P ¼ 0.17; n ¼ 25) þ1170 (P ¼ 0.51; n ¼ 19) 0.96
Postoperative complications
Early complications
Pupillary block 0 1 d
Choroidal effusionx 0 2 d
Other complications
CMEk 3 (7) 4 (10) 0.71
IOP increase 12 (28) 9 (21) 0.62
Redislocation{ 0 1 d
NAION 1 0 d
Retinal detachment 0 0 d
Endophthalmitis 0 0 d
BCVA ¼ best-corrected visual acuity; CME ¼ cystoid macular edema; CMT ¼ central macular thickness; ECD ¼ endothelial cell density; IOP ¼
intraocular pressure; logMAR ¼ logarithm of the minimum angle of resolution; NAION ¼ nonarteritic anterior ischemic optic neuropathy.
Statistical analysis was not performed for these complications because of the low number of cases, hence no P values are presented.
*P value for changes within the group (before to after surgery).
yComparison between groups.
zAnalyzed only for patients with satisfactory optical coherence tomography recordings both before and after surgery.
xNonhemorrhagic; spontaneous regression without need for treatment.
{Disenclavation of the temporal iris clip, successfully re-enclavated.
kTwo of the cases registered as complications in the repositioning group had a few cysts in macula before surgery (chronic and idiopathic uveitis, respectively)
that deteriorated after surgery.
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worsening of macular edema that was present before sur-
gery, 1 eye had intraocular hemorrhage without complete
regress, and 1 eye had ﬂuid misdirection syndrome. Other
known reasons were advanced-stage glaucoma treatment,
various macular conditions, and nonarteritic anterior
ischemic optic neuropathy. These results ﬁnd support in
another relevant IOL dislocation study4 that likewise
reported a worse postoperative BCVA in 23% of the
patients.
One could speculate whether exchange surgery with an
iris-claw IOL leads to increased endothelial cell loss because
of the large corneal wound, surgical manipulation near the
corneal endothelium, frequent need for anterior vitrectomy,
and the expected postoperative inﬂammation after iris ﬁxa-
tion. Likewise, extrusion of the lens nucleus through a small
pupil has been shown to increase postoperative inﬂamma-
tion, at least in extracapsular cataract extraction.28 A
previous IOL dislocation study demonstrated signiﬁcantly
more severe postoperative inﬂammation at day 1 in eyes
that underwent iris ﬁxation compared with eyes that
underwent scleral ﬁxation.22 Furthermore, that study founda tendency toward greater postoperative endothelial cell
loss in the iris ﬁxation group. However, the latter result
was not signiﬁcant. In the present study, we found a
nonsigniﬁcant postoperative ECD loss of 3% in the
repositioning group and a signiﬁcant postoperative ECD
loss of 10% in the exchange group. The difference
between the 2 groups was statistically signiﬁcant. These
decreases are quite modest compared with endothelial cell
loss after extracapsular cataract extraction or
phacoemulsiﬁcation cataract surgery.29 The difference
between IOL repositioning and IOL exchange thus is most
important to consider in patients with a known
compromised corneal endothelium before IOL dislocation
surgery. It also should be mentioned that the ECD
comparison in our study was limited by data missing for
various reasons in both groups. Thus, one should be
cautious in interpreting these results.
The main strength of this study is the prospective, ran-
domized research design. In addition, 1 surgeon who is well
experienced in both procedures performed all the operations.
Furthermore, we enrolled a fairly high number of patients
compared with other studies. The sample size still may be a7
Table 4. Eyes with Worsening Best-Corrected Visual Acuity 6 Months after Surgery
Best-Corrected Visual Acuity*
Presumed Cause of Visual Impairment after SurgeryEye No. Preoperative Postoperative
Repositioning group
1 0.04 0.62 Intraocular hemorrhage during surgery without complete regress, minor corneal edema
2 0.20 0.48 Fluid misdirection syndrome during surgery
3 0.04 0.10 Advanced-stage glaucoma treatment (trabeculectomy)
4 0.46 0.54 Chronic uveitis with worsening of preexisting CME
5 0.16 0.34 Myopic CNV with worsening macular edema
6 0.64 0.86 Nonarteritic anterior ischemic optic neuropathy
7 0.26 0.48 Nonneovascular AMD
8 0.30 0.44 Nonneovascular AMD
9 0.46 0.52 Unknown; comorbidity with lamellar macular hole also present before surgery
Exchange group
1 0.22 0.54 Postoperative CME
2 0.16 0.38 Postoperative CME
3 0.20 0.38 Postoperative CME
4 0.66 1.00 Advanced-stage glaucoma treatment (cyclodiode laser)
5 0.12 0.32 Advanced-stage glaucoma treatment (trabeculectomy)
6 0.62 3.00 Advanced-stage glaucoma, possible central retinal venous occlusion, comorbidity with malignancy
7 0.82 1.10 Unknown; comorbidity with advanced-stage glaucoma and serious Fuchs dystrophy
8 0.12 0.28 Unknown; comorbidity with signs of epiretinal ﬁbrosis
9 1.02 1.28 Unknown; comorbidity with previous retinal detachment, retinal atrophy
10 0.12 0.30 Unknown; may have been related to dry eye with some corneal epitheliopathy, comorbidity
with glaucoma
11 0.02 0.12 Unknown
AMD ¼ age-related macular degeneration; CME ¼ cystoid macular edema; CNV ¼ choroidal neovascularization.
*Logarithm of the minimum angle of resolution units.
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detect small group differences in postoperative outcomes
and complications that may be clinically relevant. However,
a compromise had to be made between the number of
enrolled patients and the duration of the study. A relatively
short follow-up is another limitation, especially in the
comparison of pronounced iris atrophy, impact on the
corneal endothelium, and redislocation resulting from suture
breakage, suture slippage, or disenclavation, all of which
may occur several years after surgery. Nevertheless, 6
months was considered a relevant follow-up period because
of the high mean age of the patients. There was a relatively
high loss to follow-up resulting from serious disease and 1
death. Although expected in the relevant patient group, this
is a limitation of the study.
Despite a few limitations, this study provides several
clinical implications. Both IOL repositioning by scleral su-
turing and exchange with a retropupillary iris-claw IOL
seem to be highly acceptable treatment choices. In younger
patients without posterior vitreous detachment, IOL repo-
sitioning should be considered because of a lower risk of
vitreous loss during surgery. Intraocular lens repositioning
also may be a better choice in patients with poorly dilated
pupils to reduce the risk of iris injury. In cases where pa-
tients are using anticoagulant medication that cannot be
discontinued before surgery (no cases in our study), IOL
exchange surgery may be a safer choice because of a ten-
dency of a lower risk for intraocular hemorrhage. Further-
more, IOL exchange has the advantages of being able to
adjust patient refraction and shorter surgical time. A
recommendation regarding glaucoma and IOP will be8discussed in another article (Kristianslund et al 2016, un-
published data).
In conclusion, thisﬁrst randomized clinical trial examining
surgical methods for late in-the-bag IOL dislocation revealed
that IOL repositioning by scleral suturing and IOL exchange
with a retropupillary iris-claw IOL seem to have similar ef-
ﬁcacy in terms of visual outcome. Both operation methods
seem to be safe with few serious complications, although
some differences in perioperative parameters were demon-
strated. A follow-up beyond 6months is required to assess the
long-term efﬁcacy and safety of these 2 operation methods.References
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